2 results match your criteria: "St Luc Hospital-Catholic University of Louvain[Affiliation]"
Short-Term Results of Eluvia Paclitaxel-Eluting Stent in External Iliac and Femoropopliteal Lesions.
Surg Technol Int
November 2017
Cardiovascular and Thoracic Surgery Department, St Luc Hospital Catholic University of Louvain, Brussels, Belgium.
Introduction: The aim of this study was to independently evaluate the real-world performances of Eluvia paclitaxel drug-eluting stents (DES) (Boston Scientific, Marlborough, Massachusetts) for the treatment of external iliac and femoropopliteal artery lesions.
Materials And Methods: We prospectively collected, and retrospectively reviewed, data for all patients who underwent an endovascular treatment with an Eluvia DES for the treatment of an external iliac or femoropopliteal lesion. Patient demographics, concomitant procedures, arterial lesions characteristics, procedural details, and follow-up were reviewed.
Endometrial evaluation is a very important tool in the management of breast cancer patients.
Eur J Cancer
November 2002
Department of Gynecology, St Luc Hospital-Catholic University of Louvain, Avenue Hippocrate 10B-1200 Brussels, Belgium.